2009
DOI: 10.1038/oby.2008.624
|View full text |Cite
|
Sign up to set email alerts
|

Response to “Letter to Fowler et al. 2008”

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2013
2013
2015
2015

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…ADI of all approved additives is the daily ingestion over a lifetime, without appreciable health risk, and is allocated by European Food Safety Authority (EFSA, 2009). Several studies bring in the question about the safety of food additives, mainly artificial sweeteners, reporting a similar, and sometimes stronger, relationship between the consumption of diet soda and the prevalence of metabolic syndrome, when compared to the consumption of regular soda (Nettleton et al, 2009;Fowler et al, 2008;Lutsey et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…ADI of all approved additives is the daily ingestion over a lifetime, without appreciable health risk, and is allocated by European Food Safety Authority (EFSA, 2009). Several studies bring in the question about the safety of food additives, mainly artificial sweeteners, reporting a similar, and sometimes stronger, relationship between the consumption of diet soda and the prevalence of metabolic syndrome, when compared to the consumption of regular soda (Nettleton et al, 2009;Fowler et al, 2008;Lutsey et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…3 Several NAS compounds have been FDAapproved and are generally considered safe. 3 However, several studies suggested that counterintuitive links may exist between NAS consumption and the same ailments of the metabolic syndrome they are meant to prevent, such as weight gain, 4,5 cardiovascular disease, 6,7 and type II diabetes mellitus. 8,9 Several physiological mechanisms have been suggested for these phenomena, such as stimulation of intestinal sugar absorption, 10 disruption of the ability of sweet taste to signal caloric consequences, 11,12 an increase in appetite 13 and impaired glycemic or insulin responses.…”
Section: Introductionmentioning
confidence: 99%